These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8170642)

  • 41. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial.
    Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM
    J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radioimmunoscintigraphy of recurrent colorectal carcinoma using 111In-labelled murine monoclonal antibody B72.3: a comparison with contrast-enhanced computed tomography.
    Kmiot WA; Stonelake P; Sagar G; Donovan IA; Neoptolemos JP; Notghi A; Harding LK
    Nucl Med Commun; 1993 Sep; 14(9):788-91. PubMed ID: 8233244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
    Griffin TW; Brill AB; Stevens S; Collins JA; Bokhari F; Bushe H; Stochl MC; Gionet M; Rusckowski M; Stroupe SD
    J Clin Oncol; 1991 Apr; 9(4):631-40. PubMed ID: 2066759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations in an indium-111 Fab' under conditions of utilization.
    Halpern SE; Tarburton JP; Sudora E; Hagan P
    Eur J Nucl Med; 1992; 19(6):387-93. PubMed ID: 1618229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
    Doerr RJ; Herrera L; Abdel-Nabi H
    Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
    Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radioimmune localization of occult carcinoma.
    Duda RB; Zimmer AM; Rosen ST; Gilyon KA; Webber D; Spies S; Spies W; Merchant B
    Arch Surg; 1990 Jul; 125(7):866-70. PubMed ID: 2369311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
    Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
    J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.
    Abdel-Nabi HH; Schwartz AN; Goldfogel G; Ortman-Nabi JA; Matsuoka DM; Unger MW; Wechter DG
    Radiology; 1988 Mar; 166(3):747-52. PubMed ID: 3277244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
    Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
    Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective study of the use of 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake.
    Granowska M; Jass JR; Britton KE; Northover JM
    Int J Colorectal Dis; 1989; 4(2):97-108. PubMed ID: 2746136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SPECT anti-CEA monoclonal antibody detection of occult colorectal carcinoma metastases.
    Swayne LC; Goldenberg DM; Diehl WL; Macaulay RD; Derby LA; Trivino JZ
    Clin Nucl Med; 1991 Nov; 16(11):849-52. PubMed ID: 1752096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis of local recurrence of colorectal cancer, using PET and immunoscintigraphy by means of 131I or 111In anti-CEA monoclonal antibody].
    Ito K; Nakata K; Watanabe T; Hibi K; Kasai Y; Akiyama S; Takagi H
    Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):373-9. PubMed ID: 9101544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carcinoma].
    Muxí Pradas MA; Pons Pons F; Huguet Planella M; Novell Capilla F; García-Romero RH; Trias Folch M
    Med Clin (Barc); 1996 Nov; 107(16):601-7. PubMed ID: 9064391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved detection of hepatic lesions using MoAb B72.3 and a modified 111In labelling technique in patients with recurrent colon cancer.
    Vijayakumar V; Blend MJ; Johnson DK; Seevers RH; Schnobrich KE; Bekerman C
    Nucl Med Commun; 1993 Aug; 14(8):658-66. PubMed ID: 8371891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma.
    Buchegger F; Mach JP; Pèlegrin A; Gillet M; Vogel CA; Buclin T; Ryser JE; Delaloye B; Delaloye AB
    J Nucl Med; 1995 Mar; 36(3):420-9. PubMed ID: 7884504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative analysis of anti-CEA antibody accumulation in human colorectal carcinomas.
    Bares R; Fass J; Hauptmann S; Braun J; Grehl O; Reinartz R; Buell U; Schumpelick V; Mittermayer C
    Nuklearmedizin; 1993 Apr; 32(2):65-72. PubMed ID: 8479932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma.
    Weiner GJ; Kahn D; Jochimsen PR; Bevering CG; Kisker MA
    Cancer Invest; 1994; 12(2):111-20. PubMed ID: 8131088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.